CAD and Influenza Complications

Mechanisms of Increased Risk

Influenza infection directly worsens pre-existing coronary artery disease through multiple pathophysiologic pathways, leading to higher rates of complications, hospitalizations, and death compared to healthy individuals 1, 2
The inflammatory response to viral infection produces autoantibodies to modified low-density lipoprotein, which accelerates atherosclerotic vascular injury and plaque progression 3
Direct viral colonization of vessel walls initiates local autoimmune reactions by activating antigen-presenting cells, destabilizing existing atherosclerotic plaques 3

Influenza promotes rupture of vulnerable atherosclerotic plaques, precipitating acute coronary syndromes in patients with established coronary artery disease 4

Beyond direct cardiac effects, influenza causes fluid overload and heart failure decompensation in patients with compromised cardiac reserve 4
Influenza can lead to viral pneumonia, secondary bacterial pneumonia, or co-infections that place additional hemodynamic stress on diseased coronary circulation 1, 5

Influenza-related death occurs more frequently among individuals with cardiovascular disease than among patients with any other chronic condition, underscoring the unique vulnerability of this population 5, 2, 3

Patients at extremes of age with coronary artery disease face compounded risk from both age-related and disease-related factors 1, 5
The period immediately following acute coronary syndromes represents particularly high vulnerability, as demonstrated by the FLUVACS trial showing 8% cardiovascular mortality in unvaccinated post-MI patients versus 2% in vaccinated patients at one year 3

Influenza vaccination reduces cardiovascular events with a relative risk of 0.64 (95% CI 0.48-0.86) in high-risk cardiovascular patients, with greatest benefit in those with more active coronary disease 4

Do not underestimate the severity of risk—coronary artery disease patients face higher influenza-related mortality than any other chronic disease population, requiring aggressive prevention 5, 2
Do not delay vaccination if flu season has begun, as the risk of influenza infection in an unvaccinated coronary artery disease patient is substantial and potentially fatal 4

Influenza epidemics are associated with an increased rate of cardiovascular events 6

The American Heart Association and American College of Cardiology recommend annual influenza vaccination in all patients with coronary and other atherosclerotic vascular disease, with vaccination coverage levels among persons with CVD remaining only 34% nationally 7, 8